Document is current
Any future updates will be listed below
-
Authors
Watanabe, Kaede
Noguchi, Shohei
Shiko, Yuki
Sakamaki, Daisuke
Kawasaki, Yohei
Mazda, Yusuke
-
Funding
Funding for this research was provided by:
Saitama Medical University (04F116)
Kaken Pharmaceutical (23K15585)
- License Information
-
More Information
Article History
Received: 17 September 2025
Revised: 26 October 2025
Accepted: 14 November 2025
First Online: 29 December 2025
Declarations
:
: SN is a board officer of OASIS Clinical Partners, Inc., and holds 10% of its non-public shares. YM holds 80% of non-public shares of OASIS Clinical Partners, Inc. The other authors declare no conflicts of interest.
